Abstract: An ammonia plant having a first and second reactor and a start-up oven having at least one first heat exchanger. The first reactor operates under a higher internal pressure than the second reactor. The start-up oven is connected via a piping system for at least one synthesis gas to the first and second reactor. Ammonia is produced by heating synthesis gas in the start-up oven and transferring the heated synthesis gas to the first reactor for initiating the chemical reaction. Synthesis gas is heated with the same start-up oven and is transferred to the second reactor for initiating the chemical reaction, wherein high-pressure synthesis of ammonia occurs in the first reactor and low-pressure synthesis of ammonia occurs in the second reactor at a lower process pressure than in the first reactor.

Abstract: An ammonia plant having a first and second reactor and a start-up oven having at least one first heat exchanger. The first reactor operates under a higher internal pressure than the second reactor. The start-up oven is connected via a piping system for at least one synthesis gas to the first and second reactor. Ammonia is produced by heating synthesis gas in the start-up oven and transferring the heated synthesis gas to the first reactor for initiating the chemical reaction. Synthesis gas is heated with the same start-up oven and is transferred to the second reactor for initiating the chemical reaction, wherein high-pressure synthesis of ammonia occurs in the first reactor and low-pressure synthesis of ammonia occurs in the second reactor at a lower process pressure than in the first reactor.

Abstract: The invention relates to 4-cyanophenyl, 2-sulfanyl, 1-phenyl pyrimidine derivatives, processes for their preparation, and pharmaceutical compositions of the same. Compounds and compositions of the invention are useful in the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development.

Abstract: The invention relates to novel dihydropyridine derivatives, of Formula (I) processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases.

Abstract: This invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel 1-Phenyl-3,4-dihydropyrimidin-2(1H)-one derivatives having the formula processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel dihydropyridine derivatives, of Formula (I) processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases.

Abstract: The invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.

Abstract: In this process for the selective noncatalytic reduction of the emission of pollutants from oil-fired boiler plants, chemical compounds which affect the combustion process are admixed, in solutions miscible with the liquid fuel, in metered amounts to the liquid fuel or to the combustion air, among these compounds being salts of organic acids, such as naphthenates, octoates, tallates, salts of sulfonic acids, saturated or unsaturated fatty acids, such as oleic acid, and tall oil, with metals from the group of K, Ba, Mg, Ca, Ce, Mn, Fe; rare earth metals; organometallic compounds, such as carbonyl compounds, mixed cyclopentadienylcarbonyl compounds, or aromatic complexes of the transition metals Fe or Mn. For the purpose of minimizing the NO.sub.